Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00802932 · ClinicalTrials.gov registry record
Pilot Study to Validate Metallic Markers for Image Guided Radiation Therapy for Breast Cancer Tx
A clinical trial, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- 61
- Enrollment target
NCT00802932 is a clinical trial that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 61 participants.
The verdict
NCT00802932 has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- 61 participants
- Enrollment target
Study Summary
The purpose of this study is to test metallic markers in the breast tissue after breast conserving surgery and to observe the metallic markers' stability in the breast for use as tumor bed markers and positioning devices for radiation treatment.
Interventions
- DEVICE Non-contrast Computed Tomography (CT) Scans (Metallic Markers)
- DEVICE Non-contrast CT Scans (Metallic Markers)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2008-03 |
| Est. Completion | 2012-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00802932
The ClinicalTrials.gov registry entry for NCT00802932 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Non-contrast Computed Tomography (CT) Scans (Metallic Markers) is the first listed.
NCT00802932 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00802932 about?
NCT00802932 is a clinical study titled "Pilot Study to Validate Metallic Markers for Image Guided Radiation Therapy for Breast Cancer Tx". The purpose of this study is to test metallic markers in the breast tissue after breast conserving surgery and to observe the metallic markers' stability in the breast for use as tumor bed markers and positioning devices for radiation treatment.
What is the current status of trial NCT00802932?
This trial is currently completed. The enrollment target is 61 participants. The study started on 2008-03. Estimated completion is 2012-10.
What interventions are being tested in trial NCT00802932?
The interventions under investigation include: Non-contrast Computed Tomography (CT) Scans (Metallic Markers) (DEVICE), Non-contrast CT Scans (Metallic Markers) (DEVICE).
Who is sponsoring clinical trial NCT00802932?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.